Peptide record

TPDB45110

Antiviral standard
26 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45110
Antiviral
Anti-infective peptides
AVPpred-BWR
standard
No
A 26-aa standard-residue antiviral peptide sequence curated from AVPpred-BWR, with an available 3D structural model.
Sequence
SGSWLRIIWDWVCSWSDFKTWLSAKI
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C152H216N36O37S1
NEQHMPY
SW
3171.67
8.93
3
2
13
+1
0.60
0.135
90.00
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
27500
8.67
7
Residue Composition
number
1
A
1
R
0
N
2
D
1
C
0
E
0
Q
1
G
0
H
3
I
2
L
2
K
0
M
1
F
0
P
5
S
1
T
5
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 2 C: 1 E: 0 Q: 0 G: 1 H: 0 I: 3 L: 2 K: 2 M: 0 F: 1 P: 0 S: 5 T: 1 W: 5 Y: 0 V: 1
Chemical Descriptors
26 reviewed residue count
C152H216N36O37S1 sequence-only estimate (linear, free termini)
3171.67 sequence-only estimate (linear, free termini)
8.93 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
0.60 sequence-only estimate (linear, free termini)
0.135 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA